Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 12 | 2009 | 965 | 1.420 |
Why?
|
| Capillaries | 5 | 2010 | 25 | 0.950 |
Why?
|
| Leukoaraiosis | 4 | 2010 | 5 | 0.880 |
Why?
|
| Cerebral Arteries | 4 | 2007 | 21 | 0.760 |
Why?
|
| Veins | 4 | 2010 | 34 | 0.680 |
Why?
|
| Microvessels | 2 | 2009 | 30 | 0.590 |
Why?
|
| Dementia, Vascular | 3 | 2009 | 10 | 0.580 |
Why?
|
| Cerebral Cortex | 4 | 2007 | 143 | 0.580 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2009 | 27 | 0.550 |
Why?
|
| Blood Vessels | 4 | 2006 | 57 | 0.520 |
Why?
|
| Alzheimer Disease | 3 | 2010 | 280 | 0.460 |
Why?
|
| Aging | 4 | 2009 | 942 | 0.390 |
Why?
|
| Collagen | 3 | 2005 | 229 | 0.390 |
Why?
|
| Fibrillar Collagens | 1 | 2010 | 2 | 0.340 |
Why?
|
| Premature Birth | 2 | 2009 | 73 | 0.330 |
Why?
|
| Cerebrovascular Circulation | 3 | 2009 | 93 | 0.330 |
Why?
|
| Alkaline Phosphatase | 5 | 2010 | 40 | 0.320 |
Why?
|
| Basement Membrane | 1 | 2010 | 9 | 0.310 |
Why?
|
| Multiple Sclerosis | 1 | 2010 | 62 | 0.310 |
Why?
|
| Temporal Lobe | 1 | 2009 | 34 | 0.300 |
Why?
|
| Congenital Abnormalities | 1 | 2009 | 9 | 0.300 |
Why?
|
| Nervous System Malformations | 1 | 2009 | 10 | 0.300 |
Why?
|
| Cranial Irradiation | 2 | 2008 | 94 | 0.290 |
Why?
|
| Brain Ischemia | 2 | 2007 | 159 | 0.280 |
Why?
|
| Cerebrovascular Disorders | 1 | 2009 | 51 | 0.280 |
Why?
|
| Pregnancy Complications | 1 | 2009 | 109 | 0.270 |
Why?
|
| Endothelium, Vascular | 2 | 2006 | 155 | 0.270 |
Why?
|
| Hippocampus | 1 | 2009 | 216 | 0.270 |
Why?
|
| Neovascularization, Physiologic | 2 | 2005 | 114 | 0.270 |
Why?
|
| Tight Junctions | 1 | 2006 | 11 | 0.250 |
Why?
|
| Radiotherapy | 1 | 2007 | 92 | 0.240 |
Why?
|
| Dementia | 1 | 2009 | 246 | 0.240 |
Why?
|
| Radiation Injuries | 1 | 2007 | 85 | 0.240 |
Why?
|
| Fetus | 2 | 2005 | 76 | 0.240 |
Why?
|
| Neurons | 2 | 2009 | 486 | 0.230 |
Why?
|
| Astrocytes | 1 | 2005 | 61 | 0.230 |
Why?
|
| Membrane Proteins | 1 | 2006 | 243 | 0.220 |
Why?
|
| Humans | 18 | 2010 | 32282 | 0.210 |
Why?
|
| Apoptosis | 2 | 2002 | 375 | 0.210 |
Why?
|
| Infant, Newborn | 6 | 2009 | 666 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2007 | 1224 | 0.190 |
Why?
|
| Stem Cells | 1 | 2005 | 321 | 0.190 |
Why?
|
| Brain Diseases | 1 | 2002 | 31 | 0.190 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 545 | 0.180 |
Why?
|
| Cognition Disorders | 3 | 2008 | 349 | 0.160 |
Why?
|
| Pregnancy | 4 | 2009 | 961 | 0.160 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2007 | 232 | 0.160 |
Why?
|
| Rats, Inbred F344 | 4 | 2008 | 151 | 0.150 |
Why?
|
| Autopsy | 3 | 2009 | 37 | 0.150 |
Why?
|
| Arterioles | 3 | 2004 | 16 | 0.150 |
Why?
|
| Gestational Age | 3 | 2009 | 125 | 0.140 |
Why?
|
| Female | 9 | 2010 | 19945 | 0.130 |
Why?
|
| Aged | 6 | 2007 | 10263 | 0.130 |
Why?
|
| Male | 9 | 2010 | 19441 | 0.120 |
Why?
|
| Infant, Premature | 3 | 2006 | 74 | 0.120 |
Why?
|
| Rats | 4 | 2008 | 1895 | 0.110 |
Why?
|
| Microcirculation | 2 | 2005 | 66 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 1083 | 0.100 |
Why?
|
| Middle Aged | 5 | 2010 | 11851 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2007 | 3900 | 0.100 |
Why?
|
| Animals | 5 | 2009 | 8199 | 0.100 |
Why?
|
| Age Factors | 2 | 2007 | 1179 | 0.100 |
Why?
|
| Adult | 3 | 2009 | 9259 | 0.080 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 6 | 0.080 |
Why?
|
| Pancreatitis | 1 | 2010 | 20 | 0.080 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2010 | 29 | 0.080 |
Why?
|
| Fibrosis | 1 | 2010 | 126 | 0.080 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2009 | 2 | 0.080 |
Why?
|
| Collagen Type IV | 1 | 2009 | 10 | 0.080 |
Why?
|
| Sclerosis | 1 | 2009 | 9 | 0.080 |
Why?
|
| Retinal Vessels | 1 | 2010 | 27 | 0.080 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2009 | 28 | 0.080 |
Why?
|
| Cell Death | 1 | 2009 | 79 | 0.080 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2008 | 37 | 0.070 |
Why?
|
| Tetrazoles | 1 | 2008 | 61 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 66 | 0.070 |
Why?
|
| Imidazoles | 1 | 2008 | 97 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2009 | 77 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2007 | 35 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 93 | 0.070 |
Why?
|
| Postmortem Changes | 1 | 2007 | 2 | 0.070 |
Why?
|
| Maze Learning | 1 | 2007 | 15 | 0.060 |
Why?
|
| Time | 1 | 2007 | 27 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2007 | 32 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 52 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2006 | 74 | 0.060 |
Why?
|
| Brain Chemistry | 1 | 2006 | 46 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2006 | 54 | 0.060 |
Why?
|
| Blood-Brain Barrier | 1 | 2006 | 52 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 44 | 0.060 |
Why?
|
| Tissue Embedding | 1 | 2004 | 2 | 0.060 |
Why?
|
| Disease Progression | 1 | 2007 | 591 | 0.050 |
Why?
|
| Cell Movement | 1 | 2005 | 167 | 0.050 |
Why?
|
| Atrophy | 1 | 2004 | 46 | 0.050 |
Why?
|
| Cadaver | 1 | 2004 | 151 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2005 | 193 | 0.050 |
Why?
|
| Ependyma | 1 | 2004 | 2 | 0.050 |
Why?
|
| Infant | 1 | 2007 | 1010 | 0.050 |
Why?
|
| Obstetric Labor, Premature | 1 | 2004 | 12 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 425 | 0.050 |
Why?
|
| Cognition | 1 | 2007 | 547 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2007 | 1233 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2004 | 72 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 408 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2005 | 461 | 0.050 |
Why?
|
| Risk Factors | 2 | 2010 | 3934 | 0.050 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 256 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2002 | 13 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cerebral Ventricles | 1 | 2002 | 13 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 51 | 0.050 |
Why?
|
| Indoles | 1 | 2002 | 65 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 637 | 0.040 |
Why?
|
| Child | 1 | 2007 | 2435 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 3519 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 70 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 83 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2007 | 91 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1534 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2010 | 2240 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2010 | 3626 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 34 | 0.010 |
Why?
|